Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal pain and cramps, iron deficiency, rectal pain, frequent fevers, and/or canker sores associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

Is your child currently experiencing IBD flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce fever, kidney stones, constant need to poop, weight loss, and/or canker sores associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children to join a Crohn’s disease clinical trial to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or CD and UC (including associated symptoms such as weight loss, fatigue, diarrhea, frequent fevers and/or joint pain), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing moderate to severe UC flare-ups? Local CD research study is testing a potential new medication to see if it may reduce recurrent diarrhea, persistent diarrhea, rectal pain, frequent fevers, and/or liver disease associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce swollen joints, loss of appetite, abdominal pain, weight loss, and/or anemia associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, unexplained weight loss, diarrhea, malnutrition, and/or liver disease associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for children aged 2 to 17 years to join a CD medical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or CD and UC (including associated symptoms such as chronic diarrhea, diarrhea, bloody stool, frequent fevers and/or eye pain), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe CD flare-ups? Local medical research study is testing a potential new medication to see if it may reduce cramping, reduced appetite, rectal pain, malnutrition, and/or liver disease associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children to join a research to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderately to severely active ulcerative colitis (including associated symptoms such as swollen joints, weight loss, constant need to poop, frequent fevers and/or eye pain), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing gastrointestinal disease flare-ups? Local CD trial is testing a potential new medication to see if it may reduce cramping, kidney stones, diarrhea, frequent fevers, and/or eye pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.